REQUEST A DEMO
Total
USD $0.00
Search more companies

Denizpharma Ilac San. Ve Tic. Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Denizpharma Ilac Sanayi Ve Ticaret Limited Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English Download a sample report

Denizpharma Ilac San. Ve Tic. Ltd. Sti. is based in Turkiye. The head office is in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It currently has a total number of 25 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 30.83% in 2020. Its total assets grew by 7.53% over the same period. Denizpharma Ilac San. Ve Tic. Ltd. Sti.’s net profit margin decreased by 0.28% in 2020.

Headquarters
No:34-a Oruc Reis Mahallesi Giyim Kent Sitesi 17.sokak Esenler
Istanbul; Marmara; Postal Code: 34235

Contact Details: Purchase the Denizpharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.

Website: http://www.denizpharma.com.tr

Basic Information
Total Employees:
Purchase the Denizpharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Denizpharma Ilac San. Ve Tic. Ltd. Sti. report to view the information.
Incorporation Date:
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Denizpharma Ilac San. Ve Tic. Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
30.83%
Total operating revenue
30.83%
Operating profit (EBIT)
-30.68%
Net Profit (Loss) for the Period
-28.18%
Total assets
7.53%
Total equity
6.28%
Operating Profit Margin (ROS)
-1.31%
Net Profit Margin
-0.28%
Return on Equity (ROE)
-2.84%
Debt to Equity Ratio
22.37%
Quick Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?